$0.32 EPS Expected for Qiagen NV (QGEN)

October 13, 2017 - By Marie Mckinney

 $0.32 EPS Expected for Qiagen NV (QGEN)

Analysts expect Qiagen NV (NASDAQ:QGEN) to report $0.32 EPS on November, 1.They anticipate $0.02 EPS change or 6.67 % from last quarter’s $0.3 EPS. QGEN’s profit would be $73.80M giving it 27.10 P/E if the $0.32 EPS is correct. After having $0.30 EPS previously, Qiagen NV’s analysts see 6.67 % EPS growth. About 1.85 million shares traded or 20.13% up from the average. Qiagen NV (NASDAQ:QGEN) has risen 54.62% since October 13, 2016 and is uptrending. It has outperformed by 37.92% the S&P500.

Qiagen NV (NASDAQ:QGEN) Ratings Coverage

Among 13 analysts covering Qiagen (NASDAQ:QGEN), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Qiagen had 21 analyst reports since August 3, 2015 according to SRatingsIntel. Independent Research upgraded Qiagen NV (NASDAQ:QGEN) on Tuesday, August 1 to “Hold” rating. On Friday, July 28 the stock rating was maintained by Piper Jaffray with “Hold”. On Thursday, November 12 the stock rating was initiated by Stifel Nicolaus with “Hold”. The firm has “Overweight” rating given on Thursday, July 30 by Barclays Capital. Jefferies maintained the stock with “Hold” rating in Monday, June 5 report. The rating was initiated by Morgan Stanley on Tuesday, September 15 with “Overweight”. Citigroup maintained Qiagen NV (NASDAQ:QGEN) on Tuesday, March 15 with “Neutral” rating. As per Wednesday, September 13, the company rating was maintained by Jefferies. Cowen & Co maintained it with “Hold” rating and $33.0 target in Wednesday, September 27 report. Bank of America upgraded the stock to “Neutral” rating in Thursday, November 3 report.

QIAGEN N.V. is a holding company. The company has market cap of $8.00 billion. The Firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. It has a 105.62 P/E ratio. The Company’s Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems.

Another recent and important Qiagen NV (NASDAQ:QGEN) news was published by Investorplace.com which published an article titled: “Qiagen NV (QGEN) Hold Recommendation Confirmed” on October 05, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.